Crime doesn’t pay trebled damages: The Tipline for 26 June 2023 is scrambling to keep its illegal boycott claims against Big Pharma alive, but there are questions about whether it has non-antitrust laws on its side. A federal court in Manhattan threw out its case earlier this year, finding that the price comparison tool could not seek antitrust relief because it encouraged consumers to illegally import prescription drugs. While its appeal continues on the east coast, PharmacyChecker hopes it can write a different script out west. Also in Tipline, Janet Yellen predicts a wave of bank consolidation.

Unlock unlimited access to all Global Competition Review content